Sequence information
Variant position: 233 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 476 The length of the canonical sequence.
Location on the sequence:
PFVQGLALYTPVVLPRSLDF
T ELDVAAEKIDRFMQAVTGWK
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human PFVQGLALYTPVVLPRSLDF-T ELDVAAEKIDRFMQAVTGWK
Gorilla PFVQGLALYTPVVLPRSLDF-T ELDVAAEKIDRFMQAVTGW
Chimpanzee PFVQGLALYTPVVLPRSLDF-T ELDVAAEKIDRFMQAVTGW
Mouse SFVQSLALFTPALFPRSLDLST DPVLATEKINRFIKAVTGW
Rat PFVESLGPFTPAIFPRSLDLST DPVLAAQKINRFVQAVTGW
Bovine PFVQSLSSFAPITLPRSLDLST DPNLAAEKINRFMQSVTGW
Sheep PFVQGLSSFAPITLPRSLDLST DPNLAAEKINRFMHSATGW
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
25 – 476
Angiotensinogen
Literature citations
Detection and characterization of new mutations in the human angiotensinogen gene (AGT).
Hixson J.E.; Powers P.K.;
Hum. Genet. 96:110-112(1995)
Cited for: VARIANTS ILE-233; ARG-235 AND CYS-272;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.